Illumina buys Solexa for $600 million
14th Nov 2006, 06:12 GMT
Illumina is to acquire biotechnology company Solexa in a stock-for-stock merger worth approximately $600 million.
Illumina buys Solexa for $600 million related news:
- Illumina to Buy Solexa for $600 Million — WSJ.com: US Business
- Illumina to buy Solexa for $600 million in stock — Reuters: Business
- Illumina buying Solexa for $600 million — United Press International - NewsTrack
- Illumina to buy Solexa for about $600M — Latest news from Silicon Valley/San Jose Business Journal
- Solexa's shares soar on $600 million buyout by Illumina — MarketWatch.com - Top Stories – Sponsored by: CyberTrader
- Solexa sold to San Diego company for $600M — bizjournals.com Economic View:Bankruptcies headlines
- Illumina Buys Solexa — Forbes.com Market News
- Illumina Acquires Solexa — socalTECH.com - Southern California High Tech News
- The Illumina headquarters in San Diego is seen in an undated ... — Business Photos - Reuters on Yahoo! News Photos
- Solexa posts narrowed Q3 loss — Latest news from East Bay Business Times
Latest news from Pharmaceutical Business Review Latest News:
- Celesio revenues, profits up
- Amgen arthritis drug shows sustained safety and efficacy
- Study supports cardiovascular safety of naproxen
- Cangene chickenpox drug granted orphan status
- Reata brain cancer therapy shows strong activity
- Novartis diabetes drug faces three month delay
- Favrille drug fails secondary goal
- Neurogen commences human testing of obesity drug
- Aeterna prostate cancer drug shows promise
- Isis says new drug effective against cholesterol